Clinical Trials Browser

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT04201561 2023-06-26

SELENIUM

Phase 3 Unknown

68 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Peripheral Nervous System Diseases

NCT05622890 2022-11-21

A Single-arm Clinical Trial of IMGN853 in Chinese Adult Patients With Platinum-resistant, Epithelial Ovarian Cancer

Phase 3 Unknown

35 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT05043402 2022-08-15

A Study of Navicixizumab in Patients With Platinum Resistant Ovarian Cancer

Phase 3 Unknown

400 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT04229615 2022-04-25

A Study of Fluzoparib±Apatinib Versus Placebo Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on First-Line Platinum-Based Chemotherapy

Phase 3 Unknown

690 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00108745 2021-09-30

Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer

Phase 3 Unknown

1,157 enrolled 15 charts

Gynecologic

Brenner Tumor, Fallopian Tube Neoplasms

NCT00954174 2021-09-30

Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer

Phase 3 Unknown

637 enrolled 18 charts

GynecologicSarcoma

Carcinosarcoma, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01611766 2021-06-10

Surgery or Chemotherapy in Recurrent Ovarian Cancer (SOC 1 Trial)?

Phase 3 Unknown

356 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Recurrence

NCT03693248 2019-12-10

ROCOCO

Phase 3 Unknown

298 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT03373058 2019-11-06

EHTASEOCCS

Phase 3 Unknown

310 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT00719303 2018-02-19

Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Phase 3 Unknown

1,070 enrolled

Gynecologic

Brenner Tumor, Fallopian Tube Neoplasms

NCT03180177 2018-01-24

EHNPCTASEOC

Phase 3 Unknown

263 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT00532194 2015-09-23

ICON6

Phase 3 Unknown

486 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01654146 2012-07-31

ICON8

Phase 3 Unknown

1,485 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Clinical Trials

AL3818

SELENIUM

A Single-arm Clinical Trial of IMGN853 in Chinese Adult Patients With Platinum-resistant, Epithelial Ovarian Cancer

A Study of Navicixizumab in Patients With Platinum Resistant Ovarian Cancer

A Study of Fluzoparib±Apatinib Versus Placebo Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on First-Line Platinum-Based Chemotherapy

Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer

Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer

Surgery or Chemotherapy in Recurrent Ovarian Cancer (SOC 1 Trial)?

ROCOCO

EHTASEOCCS

Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

EHNPCTASEOC

ICON6

ICON8